Michiel C.T. van Zeijl

Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease

Monique K. van der Kooij, Karijn P.M. Suijkerbuijk, Maureen J.B. Aarts et al. · Annals of Internal Medicine · 2021 · 103 citations · Full text

Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?

Maartje G. Schouwenburg, Karijn P.M. Suijkerbuijk, Rutger H.T. Koornstra et al. · Cancers · 2019 · 41 citations · Full text

Real‐world outcomes of advanced melanoma patients not represented in phase <scp>III</scp> trials

Michiel C.T. van Zeijl, Rawa K. Ismail, Liesbeth C. de Wreede et al. · International Journal of Cancer · 2020 · 36 citations · Full text

Metastatic Uveal Melanoma: Treatment Strategies and Survival—Results from the Dutch Melanoma Treatment Registry

Anouk Jochems, Monique K. van der Kooij, Marta Fiocco et al. · Cancers · 2019 · 31 citations · Full text

Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes

Maartje G. Schouwenburg, Anouk Jochems, B Leeneman et al. · Melanoma Research · 2018 · 30 citations